Cargando…

Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic. While the development of vaccines and the emergence of antiviral therapeutics is promising, alternative strategies to combat COVID-19 (and potential future pandemics) remain an unmet need. Coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deval, Jerome, Gurard-Levin, Zachary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103157/ https://www.ncbi.nlm.nih.gov/pubmed/35566268 http://dx.doi.org/10.3390/molecules27092918

Ejemplares similares

Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry
por: Scholle, Michael D., et al.
Publicado: (2021)

Reconstitution and functional characterization of SARS-CoV-2 proofreading complex
por: Ma, Zhijun, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 replication complex elongation and proofreading activity
por: Jones, Alisha N., et al.
Publicado: (2022)

Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence
por: Lin, Liangyu, et al.
Publicado: (2022)

Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
por: Liu, Cheng, et al.
Publicado: (2021)

Coupling of N7-methyltransferase and 3′-5′ exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading
por: Yan, Liming, et al.
Publicado: (2021)

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2021)

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2022)

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme
por: Liu, Chang, et al.
Publicado: (2021)

Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
por: Scholle, Michael D., et al.
Publicado: (2022)

Substrate specificity and proposed structure of the proofreading complex of T7 DNA polymerase
por: Dangerfield, Tyler L., et al.
Publicado: (2022)

Dissecting and tuning primer editing by proofreading polymerases
por: Gohl, Daryl M, et al.
Publicado: (2021)

Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
por: Gurard-Levin, Zachary A., et al.
Publicado: (2020)

Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
por: Vandyck, Koen, et al.
Publicado: (2021)

DNA polymerase δ proofreads errors made by DNA polymerase ε
por: Bulock, Chelsea R., et al.
Publicado: (2020)

A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Sarma, Himakshi, et al.
Publicado: (2022)

Guanine-rich sequences inhibit proofreading DNA polymerases
por: Zhu, Xiao-Jing, et al.
Publicado: (2016)

Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
por: Jockusch, Steffen, et al.
Publicado: (2020)

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
por: Cannalire, Rolando, et al.
Publicado: (2020)

Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
por: Jhuti, Diya, et al.
Publicado: (2022)

Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening
por: Khater, Shradha, et al.
Publicado: (2021)

DNA polymerase proofreading: active site switching catalyzed by the bacteriophage T4 DNA polymerase
por: Fidalgo da Silva, Elizabeth, et al.
Publicado: (2007)

A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
por: Romano, Maria, et al.
Publicado: (2020)

A Proofreading Mutation with an Allosteric Effect Allows a Cluster of SARS-CoV-2 Viruses to Rapidly Evolve
por: Mack, Andrew H, et al.
Publicado: (2023)

Wastewater surveillance of SARS-CoV-2 in Bangladesh: Opportunities and challenges
por: Haque, Rehnuma, et al.
Publicado: (2022)

Replicative DNA Polymerase δ but Not ε Proofreads Errors in Cis and in Trans
por: Flood, Carrie L., et al.
Publicado: (2015)

Transcriptional accuracy modeling suggests two-step proofreading by RNA polymerase
por: Mellenius, Harriet, et al.
Publicado: (2017)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
por: Daikopoulou, Vasiliki, et al.
Publicado: (2021)

Analysis of critical protein–protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides
por: Arabi-Jeshvaghani, Fatemeh, et al.
Publicado: (2023)

Single-molecule FRET reveals proofreading complexes in the large fragment of Bacillus stearothermophilus DNA polymerase I
por: Christian, Thomas V., et al.
Publicado: (2018)

Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021)

Proofreading exonuclease on a tether: the complex between the E. coli DNA polymerase III subunits α, ε, θ and β reveals a highly flexible arrangement of the proofreading domain
por: Ozawa, Kiyoshi, et al.
Publicado: (2013)

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
por: Coke, Christopher J., et al.
Publicado: (2021)

Handbook for proofreading
por: Anderson, Laura Killen 1938-
Publicado: (1994)

Mutation tendency of mutator Plasmodium berghei with proofreading-deficient DNA polymerase δ
por: Honma, Hajime, et al.
Publicado: (2016)

Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
por: Haradhvala, N. J., et al.
Publicado: (2018)

Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex
por: Wu, Jiqin, et al.
Publicado: (2021)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

Structure and function of SARS-CoV-2 polymerase
por: Hillen, Hauke S
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_prsbgqehvl37fo8fnog5ee8cdf